Browse studies

Find your next paid study

27 recruiting studies matching your filters

Vitamin D Effects on Immune Microenvironment of Nonmelanoma Skin Cancer After Photodynamic Therapy (PDT)

This research study is for people who have been diagnosed with a nonmelanoma skin cancer (either basal cell carcinoma or squamous cell carcinoma) and are plann…

Nonmelanoma Skin CancerBasal Cell CarcinomaSquamous Cell Carcinoma

Estimated

~$10 – $750

Actual pay is set by the research site.

Case Comprehensive Cancer CenterNCT07241585

Phase 1

Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell Carcinomas

This research study is testing combination Blue-light photodynamic therapy and Sonidegib as a possible treatment for people with multiple basal cell carcinoma …

Basal Cell Carcinoma (BCC)

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Nathalie ZeitouniNCT06623201

Phase 2

Randomized Phase II Trial Neoadjuvant Nivolumab + Relatlimab (Opdualag) Versus Nivolumab for Resectable High-Risk Basal Cell Carcinoma

This is a Phase 2 clinical trial with a 2:1 randomization comparing neoadjuvant Nivolumab + Relatlimab (Opdualag) vs neoadjuvant Nivolumab in patients with res…

Basal Cell Carcinoma

Estimated

~$75 – $2,000

Actual pay is set by the research site.

University of California, San DiegoNCT06624475

Familial Investigations of Childhood Cancer Predisposition

NOTE: This is a research study and is not meant to be a substitute for clinical genetic testing. Families may never receive results from the study or may recei…

Acute LeukemiaAdenomatous PolyposisAdrenocortical Carcinoma+43 more

Estimated

~$10 – $750

Observational

Investigation of Standard Excision Surgical Margins Using Two Photon Fluorescence Microscopy

The goal of this clinical trial is to compare the use of two photon fluorescence microscopy for detecting residual basal cell carcinoma during standard local e…

Basal Cell Carcinoma

Estimated

~$10 – $750

Actual pay is set by the research site.

University of RochesterNCT06473103

Phase 1

A Phase 1/2 Open Label, Dose Escalation and Expansion Study of MDNA11, IL-2 Superkine, Administered Alone or in Combination With Immune Checkpoint Inhibitor in Patients With Advanced Solid Tumors

This is a Phase 1/2, multi-center, open-label, dose-escalation and expansion study to evaluate safety and tolerability, PK, pharmacodynamic, and early signal o…

Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more

Estimated

Phase 1

Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Patients With Solid Tumors

This is a pilot clinical trial determining the effect of a Methionine-reduced diet on serum levels in subjects with solid tumors. These are subjects who will r…

AdenocarcinomaBasal Cell CarcinomaSquamous Cell Carcinoma+12 more

Estimated

~$150 – $3,000

Actual pay is set by the research site.

University of California, IrvineNCT07628634

Phase 1

A Phase 1, First-In-Human, Single and Multiple Ascending Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Clinical Efficacy of Intralesional FLD-103 in Subjects With Basal Cell Carcinoma (BCC).

The goal of this clinical trial is to determine safety, tolerability, pharmacokinetics, preliminary efficacy, and Maximum Tolerable Dose (MTD), of intralesiona…

Nodular Basal Cell Carcinoma

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Feldan TherapeuticsNCT07670858

Phase 2

A Phase 2 Study of Intratumoral Administration of L19IL2/L19TNF in Locally Advanced Basal Cell Carcinoma Patients Progressing or Intolerant to Systemic Treatment.

Open-label, single-arm, multicentre study in patients with locally advanced BCC amenable to intratumoral injection, who have progressed on or are intolerant to…

Locally Advanced Basal Cell Carcinoma

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Philogen S.p.A.NCT07227870

Phase 1

A Phase 2 Study of Nivolumab and Ipilimumab in Combination With Sirolimus and Prednisone in Kidney Transplant Recipients With Selected Unresectable or Metastatic Cutaneous Cancers

This phase II trial tests the combination of nivolumab and ipilimumab with sirolimus and prednisone for the treatment of skin (cutaneous) cancer that cannot be…

Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+10 more

Estimated

~$150 – $2,700

Actual pay is set by the research site.

Phase 2

Combination of 5-Fluorouracil and Calcipotriene in the Treatment of Superficial Basal Cell Carcinomas and Squamous Cell Carcinomas in Situ

The investigators will compare the application of two different creams for the treatment of low-risk skin cancers-superficial basal cell carcinoma (sBCC) and s…

Superficial Basal Cell CarcinomaSquamous Cell Carcinoma in Situ

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Boston UniversityNCT05381597

Phase 1

An Open-Label Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma

This study will be a multicenter, prospective, open label, one-arm study intended to assess the Safety and Efficacy of EscharEx (EX-02) in the treatment of Bas…

Superficial Basal Cell CarcinomaNodular Basal Cell Carcinoma

Estimated

~$150 – $4,200

Actual pay is set by the research site.

MediWound LtdNCT05157763